Most patients with hidradenitis suppurativa are dissatisfied with their treatment and do not know about all treatment options.

Childhood asthma risk may be predicted based on the intensity of respiratory signs and symptoms during the first year of life.

The Trump administration's overall freeze in funding from the National Institutes of Health may mean fewer new treatments.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...

Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.

RFK Jr expressed "hope" that "many more" states would ban water fluoridation and called fluoride a “dangerous neurotoxin." ...

The US Senate confirmed the appointment of TV celebrity Dr Mehmet Oz to head the Centers for Medicare and Medicaid Services.

The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Patients with advanced Merkel cell carcinoma had significant increases in survival rates following FDA approval of immune checkpoint inhibitors.

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

Brian King, the FDA's top tobacco regulator, saw lower rates of teen vaping nationwide before being removed from his position this week.